Christie Clinic’s Vein & Vascular Center is participating in the DETOUR II clinical trial, an international multicenter clinical trial designed to evaluate the safety and effectiveness of a new procedure to treat patients with clogged leg arteries caused by severe peripheral artery disease (PAD).
The DETOUR II trial will evaluate the safety and effectiveness of the DETOUR™ System, which received IDE approval from the FDA in November of 2017. Developed by PQ Bypass, the system was designed to enable a percutaneous femoropopliteal bypass in patients with long blockages caused by PAD. This procedure is performed via a minimally-invasive endovascular approach, which creates a new pathway designed to re-direct oxygen-rich blood around the diseased part of the vessel, with the goal of improving blood flow to the lower leg and foot of the patient.
To learn more about Christie Clinic’s Vein & Vascular Center, visit https://veinvascular.christieclinic.com/. For more information about the trial, please contact Lauryn Garland at email@example.com.